Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05360615
PHASE1
The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors
Sponsor: Chulalongkorn University
View on ClinicalTrials.gov
Summary
Effects of Empagliflozin compared with placebo in post severe acute kidney injury survivors, evaluated by MAKE365.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
147
Start Date
2022-07-01
Completion Date
2026-07-01
Last Updated
2025-08-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Empagliflozin 10 MG
SGLT2 inhibitors
DRUG
Placebo
Placebo
Locations (1)
Central Chest Institute of Thailand
Nonthaburi, Mueang Nonthaburi District, Thailand